Publikationen von Klaus-Armin Nave

Ip, C. W.; Kroner, A.; Crocker, P. R.; Nave, K.-A.; Martini, R.: Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiology of Disease 25 (1), S. 105 - 111 (2007)

Meyer zu Hörste, G.; Prukop, T.; Liebetanz, D.; Möbius, W.; Nave, K.-A.; Sereda, M. W.: Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Annals of Neurology 61 (1), S. 61 - 72 (2007)

Wehr, M. C.; Laage, R.; Bolz, U.; Fischer, T. M.; Grünewald, S.; Scheek, S.; Bach, A.; Nave, K.-A.; Rossner, M. J.: Monitoring regulated protein-protein interactions using split TEV. Nature Methods 3 (12), S. 985 - 993 (2006)

Kaga, Y.; Shoemaker, W. J.; Furusho, M.; Bryant, M.; Rosenbluth, J.; Pfeiffer, S. E.; Oh, L.; Rasband, M.; Lappe-Siefke, C.; Yu, K. et al.; Ornitz, D. M.; Nave, K.-A.; Bansal, R.: Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. The Journal of Neuroscience 26 (47), S. 12339 - 12350 (2006)

Krämer-Albers, E.-M.; Gehrig-Burger, K.; Thiele, C.; Trotter, J.; Nave, K.-A.: Perturbed Interactions of Mutant Proteolipid Protein/DM20 with Cholesterol and Lipid Rafts in Oligodendroglia: Implications for Dysmyelination in Spastic Paraplegia. The Journal of Neuroscience 26 (45), S. 11743 - 11752 (2006)

Weishaupt, J. H.; Bartels, C.; Pölking, E.; Dietrich, J.; Rohde, G.; Poeggeler, B.; Mertens, N.; Sperling, S.; Bohn, M.; Hüther, G. et al.; Schneider, A.; Bach, A.; Sirén, A.-L.; Hardeland, R.; Bähr, M.; Nave, K.-A.; Ehrenreich, H.: Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. Journal of Pineal Research 41 (4), S. 313 - 323 (2006)

Meyer zu Hörste, G.; Nave, K.-A.: Animal models of inherited neuropathies. Current Opinion in Neurology 19 (5), S. 464 - 473 (2006)

Nave, K.-A.; Salzer, J. L.: Axonal regulation of myelination by neuregulin 1. Current Opinion in Neurobiology 16 (5), S. 492 - 500 (2006)

Thurnherr, T.; Benninger, Y.; Wu, X.; Chrostek, A.; Krause, S. M.; Nave, K.-A.; Franklin, R. J. M.; Brakebusch, C.; Suter, U.; Relvas, J. B.: Cdc42 and Rac1 signaling are both required for and act synergistically in the correct formation of myelin sheaths in the CNS. The Journal of Neuroscience 26 (40), S. 10110 - 10119 (2006)

Rossner, M. J.; Hirrlinger, J.; Wichert, S. P.; Boehm, C.; Newrzella, D.; Hiemisch, H.; Eisenhardt, G.; Stuenkel, C.; Ahsen, O. v.; Nave, K.-A.: Global transcriptome analysis of genetically identified neurons in the adult cortex. The Journal of Neuroscience 26 (39), S. 9956 - 9966 (2006)

Ip, C. W.; Kroner, A.; Bendszus, M.; Leder, C.; Kobsar, I.; Fischer, S.; Wiendl, H.; Nave, K.-A.; Martini, R.: Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. The Journal of Neuroscience 26 (31), S. 8206 - 8216 (2006)

Kashani, A. H.; Qiu, Z.; Jurata, L.; Lee, S.-K.; Pfaff, S.; Goebbels, S.; Nave, K.-A.; Ghosh, A.: Calcium activation of the LMO4 transcription complex and its role in the patterning of thalamocortical connections. The Journal of Neuroscience 26 (32), S. 8398 - 8408 (2006)

Monory, K.; Massa, F.; Egertova, M.; Eder, M.; Blaudzun, H.; Westenbroek, R.; Kelsch, W.; Jacob, W.; Marsch, R.; Ekker, M. et al.; Long, J.; Rubenstein, J. L.; Goebbels, S.; Nave, K.-A.; During, M.; Klugmann, M.; Wölfel, B.; Dodt, H.-U.; Zieglgänsberger, W.; Wotjak, C. T.; Mackie, K.; Elphick, M. R.; Marsicano, G.; Lutz, B.: The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51 (4), S. 455 - 466 (2006)

Rosenbluth, J.; Nave, K.-A.; Mierzwa, A.; Schiff, R.: Subtle myelin defects in PLP-null mice. Glia 54 (3), S. 172 - 182 (2006)

Benninger, Y.; Colognato, H.; Thurnherr, T.; Franklin, R. J. M.; Leone, D. P.; Atanasoski, S.; Nave, K.-A.; ffrench-Constant, C.; Suter, U.; Relvas, J. B.: β1-integrin signaling mediates premyelinating oligodendrocyte survival but is not required for CNS myelination and remyelination. The Journal of Neuroscience 26 (29), S. 7665 - 7673 (2006)

Fowler, J. H.; Edgar, J. M.; Pringle, A.; McLaughlin, M.; McCulloch, J.; Griffiths, I. R.; Garbern, J. Y.; Nave, K.-A.; Dewar, D.: α-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid-mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein. Journal of Neuroscience Research 84 (1), S. 68 - 77 (2006)

Nobbio, L.; Gherardi, G.; Vigo, T.; Passalacqua, M.; Melloni, E.; Abbruzzese, M.; Mancardi, G.; Nave, K.-A.; Schenone, A.: Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease. European Journal of Neuroscience 23 (6), S. 1445 - 1452 (2006)

Trajkovic, K.; Dhaunchak, A. S.; Goncalves, J. T.; Wenzel, D.; Schneider , A.; Bunt, G.; Nave, K.-A.; Simons, M.: Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites. Journal of Cell Biology 172 (6), S. 937 - 948 (2006)

Goebbels, S.; Bormuth, I.; Bode, U.; Hermanson, O.; Schwab, M. H.; Nave, K.-A.: Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice. Genesis 44 (12), S. 611 - 621 (2006)

Meyer zu Hörste, G.; Prukop, T.; Nave, K.-A.; Sereda, M. W.: Myelin disorders: causes and perspectives of Charcot-Marie-Tooth neuropathy. Journal of Molecular Neuroscience 28 (1), S. 77 - 88 (2006)